Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data
The Litigation Landscape: Has expanded rapidly as medical research continues to establish correlations between GLP-1 drug use and sudden vision impairment
A membership model provides ongoing care and monitoring
Hawkins T, Marks JM, Plummer VM, Greaves MW
When patients are wary of GLP-1s based on influencer warning content, some go looking for something that feels more cutting edge or exclusive
It has to be the drug plus lifestyle modifications. Still, the medications can be beneficial, and its a misconception that relying on a drug for weight loss is always dangerous, adds Dr
